FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203155293> ?p ?o ?g. }

• W3203155293 endingPage "157" @default.
• W3203155293 startingPage "141" @default.
• W3203155293 abstract "Antibody therapeutics can be associated with unwanted immune responses resulting in the development of anti-drug antibodies (ADA). Optimal methods to evaluate the potential effects of ADA on clinical outcomes in oncology are not well established. In this study, we assessed efficacy and safety, based on ADA status, in patients from over 10 clinical trials that evaluated the immune checkpoint inhibitor atezolizumab as a single agent or as combination therapy for several types of advanced cancers. ADA can only be observed post randomization, and imbalances in baseline prognostic factors can confound the interpretation of ADA impact. We applied methodology to account for the confounding effects of baseline clinical characteristics and survivorship bias on efficacy. Adjusted meta-analyses revealed that despite numerical differences in overall survival and progression-free survival between ADA-positive and ADA-negative patients from some studies, ADA-positive patients from studies with an overall treatment effect derived benefit from atezolizumab, compared with their adjusted controls. Based on large, pooled populations from atezolizumab monotherapy or combination studies, unadjusted descriptive analyses did not identify a clear relationship between ADA status and frequency or severity of adverse events. Data also suggested that any ADA impact is not driven by neutralizing activity. Collectively, this exploratory analysis suggests that the potential for ADA development should not impact treatment decisions with atezolizumab." @default.
• W3203155293 created "2021-10-11" @default.
• W3203155293 creator A5029179337 @default.
• W3203155293 creator A5033819205 @default.
• W3203155293 creator A5043917346 @default.
• W3203155293 creator A5046728958 @default.
• W3203155293 creator A5063300526 @default.
• W3203155293 creator A5068171378 @default.
• W3203155293 creator A5071751304 @default.
• W3203155293 creator A5078902632 @default.
• W3203155293 creator A5081573818 @default.
• W3203155293 creator A5083434070 @default.
• W3203155293 creator A5085131013 @default.
• W3203155293 date "2021-09-28" @default.
• W3203155293 modified "2023-09-27" @default.
• W3203155293 title "Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2)" @default.
• W3203155293 cites W2009854423 @default.
• W3203155293 cites W2023211244 @default.
• W3203155293 cites W2024304683 @default.
• W3203155293 cites W2046974419 @default.
• W3203155293 cites W2069506532 @default.
• W3203155293 cites W2076668534 @default.
• W3203155293 cites W2124427232 @default.
• W3203155293 cites W2144422333 @default.
• W3203155293 cites W2145476831 @default.
• W3203155293 cites W2147810684 @default.
• W3203155293 cites W2149065814 @default.
• W3203155293 cites W2181230016 @default.
• W3203155293 cites W2196578399 @default.
• W3203155293 cites W2289712604 @default.
• W3203155293 cites W2293531514 @default.
• W3203155293 cites W2475781394 @default.
• W3203155293 cites W2559804019 @default.
• W3203155293 cites W2560367415 @default.
• W3203155293 cites W2564934728 @default.
• W3203155293 cites W2567564314 @default.
• W3203155293 cites W2578864244 @default.
• W3203155293 cites W2625684877 @default.
• W3203155293 cites W2761154221 @default.
• W3203155293 cites W2777192533 @default.
• W3203155293 cites W2807965874 @default.
• W3203155293 cites W2893960509 @default.
• W3203155293 cites W2897422388 @default.
• W3203155293 cites W2924289105 @default.
• W3203155293 cites W2943887705 @default.
• W3203155293 cites W2946386783 @default.
• W3203155293 cites W2973118248 @default.
• W3203155293 cites W2973656799 @default.
• W3203155293 cites W2989956813 @default.
• W3203155293 cites W3015232330 @default.
• W3203155293 cites W3017322331 @default.
• W3203155293 cites W3025022288 @default.
• W3203155293 cites W3108008028 @default.
• W3203155293 cites W3110814768 @default.
• W3203155293 cites W3158704737 @default.
• W3203155293 cites W3195137671 @default.
• W3203155293 cites W3203155293 @default.
• W3203155293 doi "https://doi.org/10.1111/cts.13149" @default.
• W3203155293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34582105" @default.
• W3203155293 hasPublicationYear "2021" @default.
• W3203155293 type Work @default.
• W3203155293 sameAs 3203155293 @default.
• W3203155293 citedByCount "6" @default.
• W3203155293 countsByYear W32031552932021 @default.
• W3203155293 countsByYear W32031552932022 @default.
• W3203155293 countsByYear W32031552932023 @default.
• W3203155293 crossrefType "journal-article" @default.
• W3203155293 hasAuthorship W3203155293A5029179337 @default.
• W3203155293 hasAuthorship W3203155293A5033819205 @default.
• W3203155293 hasAuthorship W3203155293A5043917346 @default.
• W3203155293 hasAuthorship W3203155293A5046728958 @default.
• W3203155293 hasAuthorship W3203155293A5063300526 @default.
• W3203155293 hasAuthorship W3203155293A5068171378 @default.
• W3203155293 hasAuthorship W3203155293A5071751304 @default.
• W3203155293 hasAuthorship W3203155293A5078902632 @default.
• W3203155293 hasAuthorship W3203155293A5081573818 @default.
• W3203155293 hasAuthorship W3203155293A5083434070 @default.
• W3203155293 hasAuthorship W3203155293A5085131013 @default.
• W3203155293 hasBestOaLocation W32031552931 @default.
• W3203155293 hasConcept C118552586 @default.
• W3203155293 hasConcept C121608353 @default.
• W3203155293 hasConcept C126322002 @default.
• W3203155293 hasConcept C143998085 @default.
• W3203155293 hasConcept C197934379 @default.
• W3203155293 hasConcept C203014093 @default.
• W3203155293 hasConcept C21715850 @default.
• W3203155293 hasConcept C2775949291 @default.
• W3203155293 hasConcept C2777701055 @default.
• W3203155293 hasConcept C2780057760 @default.
• W3203155293 hasConcept C2780868878 @default.
• W3203155293 hasConcept C522805319 @default.
• W3203155293 hasConcept C535046627 @default.
• W3203155293 hasConcept C71924100 @default.
• W3203155293 hasConcept C77350462 @default.
• W3203155293 hasConcept C8891405 @default.
• W3203155293 hasConcept C95190672 @default.
• W3203155293 hasConceptScore W3203155293C118552586 @default.
• W3203155293 hasConceptScore W3203155293C121608353 @default.

• next